You have skipped the navigation, tab for page content
Knights five-eighth Jarrod Mullen.

The NRL today issued Newcastle Knights player Jarrod Mullen with a Notice of Alleged Anti-Doping Rule Violations under the NRL's Anti-Doping Policy.

This follows advice from the Australian Sports Anti-Doping Authority (ASADA) that Mullen’s  B-sample has tested positive for  an anabolic steroid, Drostanolone.

The Notice alleges that Mr Mullen breached the Policy by the Presence and Use of Drostanolone, which is prohibited by the World Anti-Doping Agency (WADA) and the NRL's Anti-Doping Policy.

Mullen was tested by ASADA on 29 November, 2016 and has been provisionally suspended from participating in any WADA compliant sport, including Rugby League, since 17 January 2017 after his  A-Sample tested positive for Drostanolone.

Under the NRL's Anti-Doping Policy, Mullen now has the opportunity to respond to the matters raised in the Notice of Alleged Anti-Doping Rule Violations.

The NRL will not be making any further comment while this process is under way.


Acknowledgement of Country

National Rugby League respects and honours the Traditional Custodians of the land and pay our respects to their Elders past, present and future. We acknowledge the stories, traditions and living cultures of Aboriginal and Torres Strait Islander peoples on the lands we meet, gather and play on.

Premier Partner

Media Partners

Major Partners

View All Partners